Results 1 to 10 of about 7,810 (157)
Kaposi's sarcoma-associated herpesvirus at 27 [PDF]
Tumour Virus Research, 2021 Kaposi's sarcoma-associated herpesvirus (KSHV) was discovered 27 years ago and its link to several pathologies – Kaposi's sarcoma, primary effusion lymphoma, and the B cell variant of Multicentric Castleman disease – is now well established.
Marta Maria Gaglia
doaj +4 more sources
Hypoxic reactivation of Kaposi's sarcoma associated herpesvirus [PDF]
Cell InsightHypoxic reactivation of Kaposi's sarcoma-associated herpesvirus (KSHV) refers to the phenomenon under low oxygen where the virus goes from latent to lytic replication.
Rajnish Kumar Singh +2 more
doaj +4 more sources
Kaposi’s Sarcoma-associated herpesvirus microRNAs [PDF]
Frontiers in Microbiology, 2012 Kaposi’s Sarcoma-associated herpesvirus (KSHV) is a human pathogenic -herpesvirus strongly associated with the development of Kaposi’s Sarcoma and B cell proliferative disorders, including primary effusion lymphoma (PEL).
Eva eGottwein
doaj +3 more sources
Insight into the Epigenetics of Kaposi's Sarcoma-Associated Herpesvirus. [PDF]
Int J Mol Sci, 2023 Epigenetic reprogramming represents a series of essential events during many cellular processes including oncogenesis. Genome of Kaposi’s sarcoma-associated herpesvirus (KSHV), an oncogenic herpesvirus is predetermined for a well-orchestrated epigenetic reprogramming once it enters into a host cell.
Srivastava A, Srivastava A, Singh RK.
europepmc +3 more sources
Pathology of Kaposi's sarcoma-associated herpesvirus infection [PDF]
Frontiers in Microbiology, 2011 Kaposi’s sarcoma-associated herpesvirus (KSHV, human herpesvirus 8, HHV-8) is a human herpesvirus, classified as a gamma-herpesvirus. KSHV is detected in Kaposi’s sarcoma (KS), primary effusion lymphoma (PEL), and some cases of multicentric Castleman’s ...
Hitomi eFukumoto +4 more
doaj +3 more sources
Kaposi’s Sarcoma-associated Herpesvirus
Berkala Ilmu Kesehatan Kulit dan Kelamin (Periodical of Dermatology and Venerology), 2016 Background: Kaposi’s sarcoma (KS) revealed by Moritz Kaposi first time in 1872. In the early 1980, the prevalence of SK began to increase dramatically.
Novia Indriyani Adisty +2 more
doaj +2 more sources
Kaposi's sarcoma-associated herpesvirus infection and Kaposi's sarcoma in Brazil [PDF]
Brazilian Journal of Medical and Biological Research, 2006 Kaposi's sarcoma (KS) became a critical health issue with the emergence of acquired immunodeficiency syndrome (AIDS) in the 1980s. Four clinical-epidemiological forms of KS have been described: classical KS, endemic KS, iatrogenic KS, and AIDS-associated
S. Ramos-da-Silva +3 more
doaj +6 more sources
Epidemiology and Transmission of Kaposi’s Sarcoma-Associated Herpesvirus [PDF]
Viruses, 2014 This review summarizes the current knowledge pertaining to Kaposi sarcoma-associated herpesvirus (KSHV) epidemiology and transmission. Since the identification of KSHV twenty years ago, it is now known to be associated with Kaposi’s sarcoma (KS ...
Veenu Minhas, Charles Wood
doaj +3 more sources
The Chromatin Landscape of Kaposi’s Sarcoma-Associated Herpesvirus [PDF]
Viruses, 2013 Kaposi’s sarcoma-associated herpesvirus is an oncogenic γ-herpesvirus that causes latent infection in humans. In cells, the viral genome adopts a highly organized chromatin structure, which is controlled by a wide variety of cellular and viral chromatin ...
Zsolt Toth, Kevin Brulois, Jae U. Jung
doaj +3 more sources
Frontiers in Cell and Developmental Biology, 2023 Kaposi’s sarcoma associated herpesvirus (KSHV) is causative agent of Kaposi’s sarcoma, Multicentric Castleman Disease and Pleural effusion lymphoma. KSHV-encoded ORF17 encodes a protease which cleaves -Ala-Ala-, -Ala-Ser- or -Ala-Thr-bonds.
Misbahuddin M Rafeeq +12 more
doaj +1 more source